FDA Approves Flortaucipir F18 For Patients Being Evaluated for Alzheimer Disease
May 29th 2020Officials from the FDA have approved flortaucipir F18 (Tauvid, Eli Lilly) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer disease in the brain called tau pathology.
Read More
Fast Track Designation Granted to Drug for KRAS-Mutated Metastatic Colorectal Cancer
May 28th 2020FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.
Read More
5 Pearls from the 2020 States Forum on Pharmacist Birth Control Services
May 28th 2020The second annual States Forum on Pharmacist Birth Control Services recently was held by the Birth Control Pharmacist project in partnership with the National Alliance of State Pharmacy Associations (NASPA).
Read More